BIOPTIMATE ApS: Financial statements 2022
CVR: 36051183
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -516,792 and a net result of DKK -3,226,334 compared with DKK -253,182 the year before. Equity in the 2022 report amounted to DKK -3,741,256.
- Gross Profit
- DKK -516,792
- Profit/Loss
- DKK -3,226,334
- Equity
- DKK -3,741,256
- Total Assets
- DKK 566,783
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -517 t. | -3.2 mio. | -3.7 mio. | - |
| 2021 | - | -317 t. | -253 t. | -515 t. | 0 |
| 2020 | - | -63 t. | -60 t. | -262 t. | 0 |
| 2019 | - | -294 t. | -290 t. | -202 t. | 1 |
| 2018 | - | 13 t. | 13 t. | 88 t. | - |
Keep an eye on BIOPTIMATE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOPTIMATE ApS has published its annual report for 2021. Gross profit came to DKK -317,091, and the net result was DKK -253,182.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2025, the company reported a gross profit of DKK -1,252,436 and a net result of DKK -1,858,649 compared with DKK -6,367,118 the year before. Equity in the 2025 report amounted to DKK -5,714,314.